These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 12057561)

  • 21. [Potential therapy for mucus hypersecretion in chronic obstructive pulmonary disease].
    Park JA; Adler KB
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(41):2890-2. PubMed ID: 17288783
    [No Abstract]   [Full Text] [Related]  

  • 22. [Cannabis and nifluril].
    Forzy G; Spyckerelle C; Scalber M; Lhermitte M; Dhondt JL
    Ann Biol Clin (Paris); 2002; 60(6):745-6. PubMed ID: 12484364
    [No Abstract]   [Full Text] [Related]  

  • 23. Characteristic comparison of three rat models induced by cigarette smoke or combined with LPS: to establish a suitable model for study of airway mucus hypersecretion in chronic obstructive pulmonary disease.
    Nie YC; Wu H; Li PB; Luo YL; Zhang CC; Shen JG; Su WW
    Pulm Pharmacol Ther; 2012 Oct; 25(5):349-56. PubMed ID: 22732689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tiotropium bromide inhibits relapsing allergic asthma in BALB/c mice.
    Bosnjak B; Tilp C; Tomsic C; Dekan G; Pieper MP; Erb KJ; Epstein MM
    Pulm Pharmacol Ther; 2014 Feb; 27(1):44-51. PubMed ID: 24090641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic aspects of the etiology and treatment of asthma.
    Meurer JR; Lustig JV; Jacob HJ
    Pediatr Clin North Am; 2006 Aug; 53(4):715-25. PubMed ID: 16873001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Controlled clinical study on the use of morniflumate in the treatment of inflammatory-degenerative diseases of the locomotor system].
    Raffaetà G; Saponati G; Terzuoli A
    G Clin Med; 1987 Oct; 68(10):507-13. PubMed ID: 3428515
    [No Abstract]   [Full Text] [Related]  

  • 27. Niflumic acid inhibits goblet cell degranulation in a guinea pig asthma model.
    Kondo M; Nakata J; Arai N; Izumo T; Tagaya E; Takeyama K; Tamaoki J; Nagai A
    Allergol Int; 2012 Mar; 61(1):133-42. PubMed ID: 22377526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-inflammatory and anti-asthmatic effects of resveratrol, a polyphenolic stilbene, in a mouse model of allergic asthma.
    Lee M; Kim S; Kwon OK; Oh SR; Lee HK; Ahn K
    Int Immunopharmacol; 2009 Apr; 9(4):418-24. PubMed ID: 19185061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mucoactive agents for airway mucus hypersecretory diseases.
    Rogers DF
    Respir Care; 2007 Sep; 52(9):1176-93; discussion 1193-7. PubMed ID: 17716385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Myrtol standardized on mucus hypersecretion and clearance of Pseudomonas aeruginosa in a rat model of chronic obstructive pulmonary disease.
    Cao L; Chen Y; Zhao Y; Zhang H; Wang S; Wang Z; Kang J
    Arzneimittelforschung; 2011; 61(12):685-92. PubMed ID: 22282955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The administration of mydocalm and donalgin in vertebro-radicular syndromes].
    Ovanesian GA; Martirosian GP
    Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(11):47-8. PubMed ID: 10578538
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pharmacological profile of roflumilast].
    Cortijo Gimeno J; Morcillo Sánchez E
    Arch Bronconeumol; 2010 Dec; 46 Suppl 10():19-24. PubMed ID: 21316552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mucus hypersecretion in asthma: intracellular signalling pathways as targets for pharmacotherapy.
    Lai HY; Rogers DF
    Curr Opin Allergy Clin Immunol; 2010 Feb; 10(1):67-76. PubMed ID: 19907312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production.
    Zhu Z; Homer RJ; Wang Z; Chen Q; Geba GP; Wang J; Zhang Y; Elias JA
    J Clin Invest; 1999 Mar; 103(6):779-88. PubMed ID: 10079098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple inflammatory hits and the pathogenesis of severe airway disease.
    Pavord ID; Birring SS; Berry M; Green RH; Brightling CE; Wardlaw AJ
    Eur Respir J; 2006 May; 27(5):884-8. PubMed ID: 16707390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contribution of IL-18-induced innate T cell activation to airway inflammation with mucus hypersecretion and airway hyperresponsiveness.
    Ishikawa Y; Yoshimoto T; Nakanishi K
    Int Immunol; 2006 Jun; 18(6):847-55. PubMed ID: 16611648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-inflammatory and anti-asthmatic effects of Viola mandshurica W. Becker (VM) ethanolic (EtOH) extract on airway inflammation in a mouse model of allergic asthma.
    Lee MY; Yuk JE; Kwon OK; Kim HS; Oh SR; Lee HK; Ahn KS
    J Ethnopharmacol; 2010 Jan; 127(1):159-64. PubMed ID: 19786084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic mucus hypersecretion, exacerbations and natural history of COPD.
    Vestbo J
    Exp Lung Res; 2005 Sep; 31 Suppl 1():63-5. PubMed ID: 16395861
    [No Abstract]   [Full Text] [Related]  

  • 39. Airway inflammation in chronic obstructive pulmonary disease: comparisons with asthma.
    Sutherland ER; Martin RJ
    J Allergy Clin Immunol; 2003 Nov; 112(5):819-27; quiz 828. PubMed ID: 14610463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A MARCKS-related peptide blocks mucus hypersecretion in a mouse model of asthma.
    Singer M; Martin LD; Vargaftig BB; Park J; Gruber AD; Li Y; Adler KB
    Nat Med; 2004 Feb; 10(2):193-6. PubMed ID: 14716307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.